✦ LIBER ✦

Ragaglitazar: a novel PPARα & PPARγ agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models

✍ Scribed by Ranjan Chakrabarti; Reeba K Vikramadithyan; Parimal Misra; Jagadheshan Hiriyan; Suryaprakash Raichur; Ravi K Damarla; Cynthia Gershome; Juluri Suresh; Ramanujam Rajagopalan

Book ID: 110007995
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 234 KB
Volume: 140
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0705463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The dual PPARα/γ agonist, ragaglitazar,

The dual PPARα/γ agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats

✍ Lucy C Pickavance; Christian L Brand; Karsten Wassermann; John P H Wilding 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 299 KB

Design and Synthesis of α-Aryloxyphenyla

Design and Synthesis of α-Aryloxyphenylacetic Acid Derivatives: A Novel Class of PPARα/γ Dual Agonists with Potent Antihyperglycemic and Lipid Modulating Activity

✍ Shi, Guo Q.; Dropinski, James F.; McKeever, Brian M.; Xu, Shihua; Becker, Joseph 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 287 KB

Ragaglitazar: The Pharmacokinetics, Phar

Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes

✍ Skrumsager, B. K.; Nielsen, K. K.; Müller, M.; Pabst, G.; Drake, P. G.; Edsberg, 📂 Article 📅 2003 🏛 Sage Publications 🌐 English ⚖ 193 KB